Annual report pursuant to Section 13 and 15(d)

Selected Quarterly Financial Data (Unaudited)

v2.4.0.6
Selected Quarterly Financial Data (Unaudited)
12 Months Ended
Dec. 31, 2012
Selected Quarterly Financial Data [Abstract]  
Selected Quarterly Financial Data (Unaudited)

Note 20 Selected Quarterly Financial Data (Unaudited)

 

                                 
    For the 2012 Quarters Ended  

(In thousands, except per share data)

  March 31     June 30     September 30     December 31  

Total revenues

  $ 8,777     $ 10,211     $ 11,795     $ 16,261  

Gross margin, excluding amortization of intangible assets

    3,790       3,657       4,308       7,411  

Loss from continuing operations

    (8,611     (10,245     (9,829     (1,064

Net loss attributable to common shareholders

    (9,171     (10,805     (10,206     (1,106

(Loss) income per share, basic and diluted:

                               

Loss from continuing operations

  $ (0.03   $ (0.04   $ (0.03   $ (0.00

Income (loss) from discontinued operations

  $ —       $ —       $ 0.00     $ —    

Net loss operations

  $ (0.03   $ (0.04   $ (0.03   $ (0.00
   
    For the 2011 Quarters Ended  

(In thousands), except per share data

  March 31     June 30     September 30     December 31  

Total revenues

  $ 6,950     $ 8,428     $ 6,807     $ 5,794  

Gross margin, excluding amortization of intangible assets

    2,772       3,538       2,790       1,636  

(Loss) income from continuing operations

    (4,749     (5,347     (6,749     10,381  

Net (loss) income attributable to common shareholders

    (6,349     (6,361     (8,836     17,884  

(Loss) income per share, basic:

                               

(Loss) income from continuing operations

  $ (0.02   $ (0.02   $ (0.02   $ 0.04  

(Loss) income from discontinued operations

  $ (0.00   $ (0.00   $ (0.01   $ 0.03  

Net (loss) income

  $ (0.02   $ (0.02   $ (0.03   $ 0.06  

(Loss) income per share, diluted:

                               

(Loss) income from continuing operations

  $ (0.02   $ (0.02   $ (0.02   $ 0.03  

(Loss) income from discontinued operations

  $ (0.00   $ (0.00   $ (0.01   $ 0.03  

Net (loss) income

  $ (0.02   $ (0.02   $ (0.03   $ 0.06  

Due to rounding, the quarterly per share amounts may not mathematically compute to the annual amount.

In October 2011, we completed the sale of our ophthalmic instrumentation business to Optos and as a result, recorded a gain of $10.6 million. Refer to Note 4. We corrected an immaterial error related to the classification of one of the intangible assets acquired as part of the CURNA acquisition. During the three months ended December 31, 2011, we reversed $0.7 million of amortization expense previously recorded. We previously recorded $0.2 million, $0.2 million and $0.3 million during each of the three month periods ended March 31, 2011, June 30, 2011 and September 30, 2011, respectively.